
Concentrix reported a fourth-quarter net loss of $1.479 billion ($23.85/sh) versus a year-ago profit of $115.65 million, driven by $1.527 billion of impairment charges and an operating loss of $1.382 billion; revenue rose to $2.552 billion from $2.448 billion and adjusted EPS was $2.95 (vs. $2.91 consensus). Management set Q1 adjusted EPS guidance of $2.57–$2.69 (below the $2.90 Street view) and FY adjusted EPS of $11.48–$12.07 (below $12.25 consensus), while projecting FY revenue of $10.035–$10.18 billion; the board approved a $0.36 quarterly dividend. The combination of heavy impairments and below-consensus forward guidance pressured shares (down ~6.6% pre-market).
Contrarian angles: Consensus focuses on headline impairment and misses cash; the market may be overpricing permanent damage — adjusted EPS beat and a maintained $0.36 dividend suggest upside if cash flows hold. Historical parallels: several outsourcers recovered within 6–12 months after large write‑downs when FCF and client retention stabilized; a disciplined 6–12 month play could capture mean reversion. Unintended consequences: aggressive shorting could trigger management defensive actions (accelerated buybacks, asset sales, dividend cut) — size positions to avoid forced exit on such events.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly negative
Sentiment Score
-0.65
Ticker Sentiment